MEDIPAN GMBH of Dahlewitz at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers Trader Service OEM


Ludwig-Erhard-Ring 3, 15827 Dahlewitz
Telephone +49 33708 4417-0
Fax +49 33708 4417-25

This company is co-exhibitor of
DiagnostikNet-BB Netzwerk Diagnostik Berlin-Brandenburg e.V.

Hall map

MEDICA 2018 hall map (Hall 3): stand F52

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Our products

Product category: Immuno assay testing

EIA - Enzymimmunoassays

 Enzyme immunoassays for the diagnostics of thyroid disorders, diabetes mellitus type 1, Rheumatoid arthritis and Myasthenia gravis

More Less

Product category: Immuno assay testing

LINE/Dot Assays (Generic Assays GmbH)

Manual or automated Immunodot-Assays for the qualitative or quantitative determination of autoantibodies in human serum or plasma.

More Less

Product category: Immuno assay testing

IFA - Immunofluorescence assays

Automated indirect immunofluorescence assays based on cell culture substrates and tissue sections for the diagnostics of systemic and organ-specific autoimmune diseases

More Less

Product category: Immuno assay testing

RIA - Radioimmuno assays

Isotope-labelled assays for the diagnostics of thyroid disorders and diabetes mellitus type 1

More Less

Product category: Immuno assay testing


Automated processing and evaluation of immunofluorescence assays, Application in the field of autoimmune disorders and for the detection of DNA damages

More Less

About us

Company details

MEDIPAN GMBH was founded in 1992 and is an independent, family company.

The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine laboratories, firstly within Germany but soon from other countries of the world too.

Later, the product portfolio expanded to include non-radioactive tests, and also tests to detect autoantibodies found in patients suffering from autoimmune type 1 diabetes. These diabetes antibody assays are now sold in more than 30 countries, from China to Chile.

MEDIPAN GMBH  is a continuously growing company, in the domestic and international diagnostic markets. Today, our company is an innovative and world renowned partner for laboratories and physicians, for the indications above and also in the fields of rheumatic and neurological disease.

In 2009, MEDIPAN GMBH became the first company in the world to introduce a commercially available system for the fully automated, objective evaluation of cell-based immunofluorescence tests. The AKLIDES® system marked a new milestone in the development of the immunofluorescence method - one of the oldest and most widespread laboratory procedures for the diagnosis of autoimmune disease. The now-possible standardization and mathematically proven prediction of antibody concentration were the reasons that the system has received several awards.

The latest development of the AKLIDES® system is its expansion to further applications:

The automated measurement of the revolutionary combination of cell-based immunofluorescence for screening with bead-based confirmation - the CytoBead® products - a development of sister company GA Generic Assays for the diagnosis of autoimmune disease - opens the opportunity for a totally new organization of laboratory processes.
The dedicated, objective and fast measurement of DNA damage and repair processes via specific fluorescence markers has the potential for many applications: individualization of radiation treatment and chemotherapy, particularly for children; assessment of metabolic or physiologic disorders; or other parameters based on the same principles.
These developments will continue and MEDIPAN GMBH is always open to new suggestions and collaborations.

More Less